Timber Hill’s AbbVie ABBV Stock Holding History

Timber Hill’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,232	Closed	-$1.06M	–	73
2018 Q1	$1.06M	Sell	11,232 -10,159	-47%	-$1.12M	0.16%	121
2017 Q4	$2.07M	Buy	+21,391	New	+$2.02M	0.13%	164
2015 Q2	–	Sell	-77,062	Closed	-$5.03M	–	2446
2015 Q1	$4.51M	Buy	77,062 +55,764	+262%	+$3.37M	0.02%	633
2014 Q4	$1.39M	Buy	+21,298	New	+$1.34M	0.01%	1235
2014 Q3	–	Sell	-41,495	Closed	-$2.3M	–	2539
2014 Q2	$2.34M	Buy	41,495 +37,213	+869%	+$1.95M	0.01%	1065
2014 Q1	$220K	Sell	4,282 -69,863	-94%	-$3.53M	﹤0.01%	2540
2013 Q4	$3.92M	Buy	74,145 +22,699	+44%	+$1.12M	0.01%	916
2013 Q3	$2.3M	Buy	51,446 +64	+0.1%	+$2.84K	0.01%	1349
2013 Q2	$2.12M	Buy	+51,382	New	+$2.25M	0.01%	1386

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Timber Hill's ABBV Position: Q2 2018 in Review

Timber Hill sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 11,232 shares — an estimated $1.06M sold.

Timber Hill first reported a position in ABBV in Q2 2013 and held it in 9 quarters. The position peaked at $4.51M in Q1 2015. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

Timber Hill reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
Timber Hill sold 11,232 AbbVie shares in Q2 2018, an estimated $1.06M.
Timber Hill first reported a position in AbbVie in Q2 2013 and held it in 9 quarters.
Timber Hill's AbbVie position peaked at $4.51M in Q1 2015.
1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.